U.S. Markets open in 1 hr 27 mins

GlaxoSmithKline plc (GSK)

New York Stock Exchange Consolidated Issue - New York Stock Exchange Consolidated Issue Delayed Price. Currency in USD
Add to watchlist
39.32+0.19 (+0.49%)
At close: 4:02PM EDT

39.63 +0.31 (0.79%)
Pre-Market: 8:00AM EDT

People also watch
AZNNVSSNYLLYBMY
Full screen
Previous Close39.13
Open39.36
Bid39.63 x 200
Ask39.64 x 3000
Day's Range39.17 - 39.41
52 Week Range37.20 - 44.54
Volume35,700
Avg. Volume2,700,135
Market Cap95.09B
Beta0.98
PE Ratio (TTM)44.28
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.99 (5.07%)
Ex-Dividend Date2017-08-09
1y Target EstN/A
  • Reuters5 hours ago

    Novartis picks retail expert for new role of digital chief

    Novartis has appointed a senior retail expert to the new post of chief digital officer, following a similar move by GlaxoSmithKline last month, underscoring how drugmakers are grappling with the impact of new technology. Pharmaceutical companies face a range of challenges from the digital world as mobile apps offer patients new ways to monitor their health and online communications with prescribers and consumers become routine. Bertrand Bodson, currently chief digital and marketing officer for Sainsbury's Argos chain, will start in his new role on Jan. 1, 2018, and report directly to CEO Joe Jimenez, the Swiss drugmaker said on Thursday.

  • Are Glaxo's Successful New Drugs Enough to Drive Growth?
    Zacks22 hours ago

    Are Glaxo's Successful New Drugs Enough to Drive Growth?

    Despite the success of new products, GlaxoSmithKline plc (GSK) believes that its overall performance has been weaker than it would have liked.

  • The Zacks Analyst Blog Highlights: Allergan, Ecolab, Exelon, GlaxoSmithKline and Rockwell Collins
    Zacksyesterday

    The Zacks Analyst Blog Highlights: Allergan, Ecolab, Exelon, GlaxoSmithKline and Rockwell Collins

    The Zacks Analyst Blog Highlights: Allergan, Ecolab, Exelon, GlaxoSmithKline and Rockwell Collins